Literature DB >> 10475369

Short-term analysis of the effects of as needed use of sertraline at 5 PM for the treatment of premature ejaculation.

S W Kim1, J S Paick.   

Abstract

OBJECTIVES: Pharmacotherapy using selective serotonin reuptake inhibitors (SSRIs) for men with primary premature ejaculation is promising. In particular, the strategy of taking a pill "as needed" may offer an attractive option. To investigate the possibility of self-therapy for the treatment of premature ejaculation, we compared the efficacy of sertraline taken as needed with that of continuous medication.
METHODS: Since 1996, we have treated 24 men with sertraline on an as needed basis for primary premature ejaculation. Sertraline was chosen from among the SSRIs because a large dose need not be divided and because peak plasma levels occur 4 to 8 hours after oral administration, making 5 PM a suitable time for administration (by which time a man may know whether sexual intercourse is likely to occur later that evening). Each patient was started on 50 mg daily for 2 weeks, and the dose was then adjusted to 50 or 100 mg on the day of intercourse only (PRN).
RESULTS: After 6 weeks, 18 men were still taking medication, and 6 had dropped out. Among the 18, the mean ejaculation latency was 23 +/- 19 seconds before treatment, 5.9 +/- 4.2 minutes after 2 weeks of 50 mg daily, 5.1 +/- 3.8 minutes after 2 weeks of 50 or 100 mg PRN, and 4.5 +/- 2.7 minutes after 4 weeks of 50 or 100 mg PRN. Mean sexual satisfaction scores (5, extremely satisfied; 0, extremely unsatisfied) for men were 0.8 +/- 0.8 before treatment, 3.8 +/- 1.2 after 2 weeks of 50 mg daily, 3.4 +/- 1.0 after 2 weeks of 50 or 100 mg PRN, and 3.2 +/- 0.7 after 4 weeks of 50 or 100 mg PRN. For their partners, mean sexual satisfaction scores were 1.1 +/- 0.7 before treatment, 3.2 +/- 1.6 after 2 weeks of 50 mg daily, 3.1 +/- 1.4 after 2 weeks of 50 or 100 mg PRN, and 3.3 +/- 1.2 after 4 weeks of 50 or 100 mg PRN. Side effects were intermittent excessive delay of ejaculation in 1 patient, fatigue in 2, and numbness in 1.
CONCLUSIONS: If our results are supported by additional long-term clinical studies, self-therapy with sertraline taken PRN at 5 PM for the treatment of premature ejaculation could be as attractive as self-injection therapy for the treatment of erectile dysfunction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10475369     DOI: 10.1016/s0090-4295(99)00187-9

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  14 in total

1.  Premature ejaculation: prevalent but poorly understood.

Authors:  J Rajfer
Journal:  Rev Urol       Date:  2000

2.  Managing early ejaculation: what does the future hold?

Authors:  Michael P O'leary
Journal:  Rev Urol       Date:  2004

Review 3.  Premature ejaculation: definition and drug treatment.

Authors:  Marcel D Waldinger
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  The efficacy of duloxetine in the treatment of premature ejaculation.

Authors:  Zahariou Athanasios; Papaioannou Polyanthi; Karagiannis George
Journal:  Int Urol Nephrol       Date:  2007       Impact factor: 2.370

Review 5.  Current and emerging treatment options for premature ejaculation.

Authors:  Murat Gul; Kadir Bocu; Ege Can Serefoglu
Journal:  Nat Rev Urol       Date:  2022-08-25       Impact factor: 16.430

Review 6.  Disorders of ejaculation.

Authors:  E A Jannini; C Simonelli; A Lenzi
Journal:  J Endocrinol Invest       Date:  2002-12       Impact factor: 4.256

7.  Safety and efficacy of tramadol hydrochloride on treatment of premature ejaculation.

Authors:  Bayoumy I Eassa; Mohamed A El-Shazly
Journal:  Asian J Androl       Date:  2012-10-29       Impact factor: 3.285

Review 8.  Late-stage clinical development in lower urogenital targets: sexual dysfunction.

Authors:  Usman Azam
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

9.  Premature ejaculation.

Authors:  Chris G McMahon
Journal:  Indian J Urol       Date:  2007-04

10.  A clinical study to assess the effectiveness of a hyaluronic acid-based procedure for treatment of premature ejaculation.

Authors:  A Littara; B Palmieri; V Rottigni; T Iannitti
Journal:  Int J Impot Res       Date:  2013-04-04       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.